MaxCyte Inc

-0.28 (-2.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.39B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.32 Million
Adjusted EPS-$0.05
See more estimates
10-Day MA$14.57
50-Day MAN/A
200-Day MAN/A
See more pivots

MaxCyte Inc Stock, NASDAQ:MXCT

22 Firstfield Road, Suite 110, Gaithersburg, Maryland 20878
United States of America
Phone: +1.301.944.1700
Number of Employees:


MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Gaithersburg, MD.